ClearPoint Neuro, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ClearPoint Neuro, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $546.00K, a 75.56% increase year-over-year.
- ClearPoint Neuro, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $311.00K, a 7.99% increase year-over-year.
- ClearPoint Neuro, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $288.00K, a 8.28% decline year-over-year.
- ClearPoint Neuro, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $314.00K, a 20.77% increase year-over-year.
- ClearPoint Neuro, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $559.00K, a 26.19% increase from fiscal 2024.
- ClearPoint Neuro, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $443.00K, a 12.45% decline from fiscal 2023.
- ClearPoint Neuro, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $506.00K, a 6.08% increase from fiscal 2022.
- ClearPoint Neuro, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $477.00K, a 112.95% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $546.00K 10-Q · filed 2026-08-03 | |
| 2025-12-31 | $559.00K 10-K · filed 2026-03-17 | |
| 2025-06-30 | $311.00K 10-Q · filed 2026-08-03 | |
| 2024-12-31 | $443.00K 10-K · filed 2026-03-17 | |
| 2024-06-30 | $288.00K 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $506.00K 10-K · filed 2025-02-26 | |
| 2023-06-30 | $314.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $477.00K 10-K · filed 2024-03-12 | |
| 2022-06-30 | $260.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $224.00K 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |